Cite

HARVARD Citation

    Macaluso, F. et al. (n.d.). P396 Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease. Journal of Crohn's and colitis. p. i528. [Online]. 
  
Back to record